Compound details
Formononetin 7-O-(2'',6''-di-O-(E-p-coumaroyl)glucoside)
| Compound ID | CDAMM00432 |
|---|---|
| Common name | Formononetin 7-O-(2'',6''-di-O-(E-p-coumaroyl)glucoside) | IUPAC name | [3,4-dihydroxy-5-[3-(4-hydroxyphenyl)prop-2-enoyloxy]-6-[3-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate |
| Molecular formula | C40H34O13 |
| Retention time | 15.31 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 723.201 | Theoretical mz | 723.207 |
| Error | 9.23 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.3033 |
| Inchi key | GSUCRXNVNQIYKV-CZJQLYNQNA-N |
|---|---|
| Smiles | O=C(OCC1OC(OC2=CC=C3C(=O)C(=COC3=C2)C=4C=CC(OC)=CC4)C(OC(=O)C=CC5=CC=C(O)C=C5)C(O)C1O)C=CC6=CC=C(O)C=C6 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Isoflavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| O43826 | SLC37A4 | Glucose-6-phosphate translocase | T47306 | SEA |
| P49862 | KLK7 | Kallikrein-7 | T79155 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |